[Treatment of hepatitis C after liver transplantation].
Samuel
Didier
D
Centre Hépatobiliaire, Hôpital Paul-Brousse, Villejuif.
Roche
Bruno
B
Feray
Cyrille
C
D000208:Acute Disease; D000818:Animals; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005838:Genotype; D006084:Graft Rejection; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology; D006526:Hepatitis C / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D007165:Immunosuppression Therapy; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use; D016031:Liver Transplantation / Q000401:mortality; D002679:Pan troglodytes; D011182:Postoperative Care; D011183:Postoperative Complications; D011300:Preoperative Care; D011379:Prognosis; D012367:RNA, Viral / Q000097:blood; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors; D013997:Time Factors; D014779:Virus Replication
D007136:Immunoglobulins; D012367:RNA, Viral; D012254:Ribavirin; D007372:Interferons